Ignite Creation Date:
2025-12-24 @ 10:52 PM
Ignite Modification Date:
2026-01-02 @ 10:04 AM
Study NCT ID:
NCT01159769
Status:
COMPLETED
Last Update Posted:
2012-04-03
First Post:
2010-07-08
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Patient Perceptions and Quality of Life Associated With the Use of Olapatadine 0.2% for the Treatment of Allergic Conjunctivitis
Sponsor:
Alcon Research
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
SMA-10-13
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None